Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MYO7A | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |
mRNA | MIEF2 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
mRNA | SLC35A5 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
mRNA | VEZF1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
mRNA | RFX3 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
mRNA | GMCL1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
mRNA | SIN3A | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
mRNA | MAPRE2 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
mRNA | BRICD5 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
mRNA | EMILIN2 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |